DE2628006C2 - Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung - Google Patents

Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung

Info

Publication number
DE2628006C2
DE2628006C2 DE2628006A DE2628006A DE2628006C2 DE 2628006 C2 DE2628006 C2 DE 2628006C2 DE 2628006 A DE2628006 A DE 2628006A DE 2628006 A DE2628006 A DE 2628006A DE 2628006 C2 DE2628006 C2 DE 2628006C2
Authority
DE
Germany
Prior art keywords
tert
glutamyl
otbu
glu
leucyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2628006A
Other languages
German (de)
English (en)
Other versions
DE2628006A1 (de
Inventor
Erich Prof. Dr. 8132 Tutzing Wünsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to DE2628006A priority Critical patent/DE2628006C2/de
Priority to CH671177A priority patent/CH636343A5/de
Priority to US05/808,517 priority patent/US4117117A/en
Priority to FR7719284A priority patent/FR2355805A1/fr
Priority to JP7393677A priority patent/JPS5318563A/ja
Publication of DE2628006A1 publication Critical patent/DE2628006A1/de
Application granted granted Critical
Publication of DE2628006C2 publication Critical patent/DE2628006C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE2628006A 1976-06-23 1976-06-23 Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung Expired DE2628006C2 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE2628006A DE2628006C2 (de) 1976-06-23 1976-06-23 Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
CH671177A CH636343A5 (de) 1976-06-23 1977-06-01 Verfahren zur herstellung eines neuen tridecapeptids.
US05/808,517 US4117117A (en) 1976-06-23 1977-06-21 Tridecapetide having gastrin effect
FR7719284A FR2355805A1 (fr) 1976-06-23 1977-06-23 Tridecapep-tide
JP7393677A JPS5318563A (en) 1976-06-23 1977-06-23 Tridecapeptide and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2628006A DE2628006C2 (de) 1976-06-23 1976-06-23 Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung

Publications (2)

Publication Number Publication Date
DE2628006A1 DE2628006A1 (de) 1977-12-29
DE2628006C2 true DE2628006C2 (de) 1986-11-27

Family

ID=5981179

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2628006A Expired DE2628006C2 (de) 1976-06-23 1976-06-23 Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung

Country Status (5)

Country Link
US (1) US4117117A (enExample)
JP (1) JPS5318563A (enExample)
CH (1) CH636343A5 (enExample)
DE (1) DE2628006C2 (enExample)
FR (1) FR2355805A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815946A (ja) * 1981-07-21 1983-01-29 Eisai Co Ltd 新規ヘプタデカペプタイド
GB9823213D0 (en) * 1998-10-26 1998-12-16 Autoplas International Limited Decoration of surfaces
US20070031511A1 (en) * 2003-04-08 2007-02-08 Baldwin Graham S Method of treatment
CN112794881B (zh) * 2021-02-09 2023-10-31 黑龙江省科学院大庆分院 一种抗肝癌十三肽nksgtysnddlsh及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2256445C3 (de) * 1972-11-17 1981-11-05 Hoechst Ag, 6000 Frankfurt Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
FR2355805A1 (fr) 1978-01-20
CH636343A5 (de) 1983-05-31
FR2355805B1 (enExample) 1981-01-09
JPS5318563A (en) 1978-02-20
US4117117A (en) 1978-09-26
JPS6228800B2 (enExample) 1987-06-23
DE2628006A1 (de) 1977-12-29

Similar Documents

Publication Publication Date Title
DE68923401T2 (de) Peptide mit T-Zellen-Helfer-Wirksamkeit.
DE69202182T2 (de) Octapeptid oder Heptapeptidderivate, Verfahren zu deren Herstellung sowie Medikamente, die diese Verbindungen enthalten und Verwendung derselben.
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DE2438350A1 (de) Peptide mit starker lh-rh/fsh-rhwirkung und verfahren zu ihrer herstellung
EP0552238A1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2634416A1 (de) Peptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2725734C2 (enExample)
DE3687532T2 (de) Zyklische hexapeptid-lhrh-antagonisten.
DE2822951A1 (de) Neue polypeptide mit thymusaktivitaet oder antagonistischer aktivitaet und verfahren zu ihrer herstellung
DE2517512A1 (de) Peptide und verfahren zu ihrer herstellung
DE3881467T2 (de) Vasokonstriktor-Peptid.
DE2659758A1 (de) Carba-derivate von somatostatin, verfahren zu ihrer herstellung und arzneimittel
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
US4405607A (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
DE2739440A1 (de) Pentapeptide und sie enthaltende arzneimittel
DE69018914T2 (de) Pharmakologisch aktive Präparate und sie enthaltende Arzneimittel.
CH639941A5 (en) Polypeptides, process for their preparation and their use
DE2601820A1 (de) Kathepsin d-inhibitoren
EP0033384A2 (de) Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
DE2751026A1 (de) Verfahren zur herstellung von peptiden, die tyrosinsulfat enthalten
DE2342862C3 (de) An beiden Kettenenden Reste von a -Aminooxycarbonsäuren aufweisende Peptide mit ACTH-Wirkung, Verfahren zu ihrer Herstellung und diese Peptide enthaltende Arzneimittel
DE2628006C3 (enExample)
JPH0631314B2 (ja) 新規なゴナドリベリン誘導体

Legal Events

Date Code Title Description
OC Search report available
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee